Trials / Completed
CompletedNCT00002181
Cidofovir as a Treatment for Herpes Simplex in Patients With AIDS
Open-Label Study of Cidofovir Gel for Acyclovir-Unresponsive Mucocutaneous Herpes Simplex Disease in Patients With AIDS.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Gilead Sciences · Industry
- Sex
- All
- Age
- 13 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to see if cidofovir gel (Forvade) is safe and effective in treating herpes simplex in patients with AIDS who do not respond to acyclovir.
Detailed description
Patients receive open-label treatment with cidofovir gel.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cidofovir |
Timeline
- First posted
- 2001-08-31
- Last updated
- 2005-06-24
Locations
15 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00002181. Inclusion in this directory is not an endorsement.